The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for KJ Shin


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification and characterization of potent, selective and metabolically stable IKKß inhibitor.EBI
The Catholic University of Korea
Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.EBI
The Catholic University of Korea
Synthesis and structure-activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer's disease.EBI
Korea Institute of Science and Technology
Discovery of potent and selective rhodanine type IKKß inhibitors by hit-to-lead strategy.EBI
Korea University
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.EBI
National Institute of Diabetes
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.EBI
Korea Institute of Science and Technology
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.EBI
Korea Institute of Science and Technology
IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.EBI
Institute of Science and Technology
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.EBI
Institute of Science and Technology
Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.EBI
Korea Institute of Science & Technology (Kist)
Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.EBI
The Catholic University of Korea
Small molecules that protect against β-amyloid-induced cytotoxicity by inhibiting aggregation of β-amyloid.EBI
Korea Institute of Science and Technology
Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation.EBI
Korea Institute of Science and Technology
Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.EBI
Korea Institute of Science & Technology (Kist)